KBC Group NV lifted its stake in shares of CIGNA Co. (NYSE:CI) by 36.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 190,723 shares of the health services provider’s stock after acquiring an additional 50,686 shares during the quarter. KBC Group NV’s holdings in CIGNA were worth $38,734,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Saratoga Research & Investment Management bought a new position in shares of CIGNA during the 3rd quarter valued at approximately $112,000. Stuart Chaussee & Associates Inc. bought a new position in shares of CIGNA during the 4th quarter valued at approximately $122,000. Horan Capital Advisors LLC. bought a new position in shares of CIGNA during the 3rd quarter valued at approximately $123,000. Cerebellum GP LLC bought a new position in shares of CIGNA during the 4th quarter valued at approximately $127,000. Finally, Grove Bank & Trust grew its stake in shares of CIGNA by 171.9% during the 3rd quarter. Grove Bank & Trust now owns 976 shares of the health services provider’s stock valued at $182,000 after acquiring an additional 617 shares during the period. Institutional investors own 88.04% of the company’s stock.

In other news, Chairman Isaiah Harris, Jr. sold 212 shares of the company’s stock in a transaction that occurred on Monday, December 11th. The stock was sold at an average price of $209.35, for a total transaction of $44,382.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Alan Muney sold 15,345 shares of the company’s stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $200.80, for a total value of $3,081,276.00. Following the sale, the executive vice president now directly owns 28,457 shares in the company, valued at $5,714,165.60. The disclosure for this sale can be found here. Insiders have sold a total of 75,080 shares of company stock worth $15,390,073 over the last ninety days. Insiders own 1.30% of the company’s stock.

CI has been the subject of a number of recent research reports. Jefferies Group boosted their price objective on CIGNA from $221.00 to $231.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Zacks Investment Research downgraded CIGNA from a “buy” rating to a “hold” rating in a research note on Friday, November 10th. Morgan Stanley boosted their price objective on CIGNA to $255.00 and gave the company an “overweight” rating in a research note on Friday, February 2nd. ValuEngine upgraded CIGNA from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Finally, BMO Capital Markets initiated coverage on CIGNA in a research note on Monday, October 16th. They set a “market perform” rating and a $210.00 price objective for the company. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company’s stock. CIGNA has a consensus rating of “Buy” and an average price target of $210.12.

Shares of CIGNA Co. (NYSE:CI) opened at $193.77 on Friday. The stock has a market capitalization of $46,175.64, a P/E ratio of 22.20, a PEG ratio of 1.14 and a beta of 0.45. CIGNA Co. has a twelve month low of $141.93 and a twelve month high of $227.13. The company has a current ratio of 0.37, a quick ratio of 0.39 and a debt-to-equity ratio of 0.38.

CIGNA (NYSE:CI) last issued its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.94 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.87 by $0.07. The business had revenue of $10.53 billion for the quarter, compared to analysts’ expectations of $10.28 billion. CIGNA had a return on equity of 18.84% and a net margin of 5.38%. The company’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same period in the prior year, the firm earned $1.87 EPS. equities research analysts predict that CIGNA Co. will post 12.9 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This story was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.thecerbatgem.com/2018/02/10/kbc-group-nv-buys-50686-shares-of-cigna-co-ci.html.

CIGNA Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.